Education
About Us
Working with TipRanks
Follow Us
China Resources Pharmaceutical Group Ltd. (HK:3320)
:3320
3320 Stock Chart & Stats
HK$4.61
HK$0.05(0.94%)
At close: 4:00 PM EST
HK$4.61
HK$0.05(0.94%)
Day’s Range― - ―
52-Week RangeHK$4.34 - HK$5.76
Previous CloseN/A
Volume6.08M
Average Volume (3M)13.76M
Market Cap
HK$29.03B
Enterprise ValueHK$100.62B
Total Cash (Recent Filing)HK$34.54B
Total Debt (Recent Filing)HK$90.96B
Price to Earnings (P/E)3.5
Beta0.79
Next Earnings
Mar 24, 2026EPS Estimate
0.23Next Dividend Ex-DateN/A
Dividend Yield2.95%
Share Statistics
EPS (TTM)0.37
Shares Outstanding6,282,510,300
10 Day Avg. Volume13,454,154
30 Day Avg. Volume13,759,791
Financial Highlights & Ratios
PEG Ratio-0.57
Price to Book (P/B)0.70
Price to Sales (P/S)0.13
P/FCF Ratio2.46
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.62
Revenue Forecast (FY)HK$276.96B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthConsistent revenue growth indicates strong market demand and effective business strategies, supporting long-term expansion and stability.
Stable Gross MarginsStable gross margins suggest effective cost management and pricing strategies, which are crucial for maintaining profitability over time.
Strong Balance SheetA strong balance sheet with moderate leverage provides financial stability and flexibility to pursue growth opportunities and withstand economic fluctuations.
Bears Say
Declining Net Profit MarginsDeclining net profit margins indicate pressure on profitability, which can affect long-term earnings potential and shareholder value if not addressed.
Zero Cash FlowsLack of cash flow generation can hinder the company's ability to invest in growth, pay down debt, and manage day-to-day operations effectively.
Declining Return On EquityA declining ROE suggests reduced efficiency in generating returns from shareholders' equity, which may impact investor confidence and capital raising abilities.
China Resources Pharmaceutical Group Ltd. News
3320 FAQ
What was China Resources Pharmaceutical Group Ltd.’s price range in the past 12 months?
China Resources Pharmaceutical Group Ltd. lowest stock price was HK$4.34 and its highest was HK$5.76 in the past 12 months.
What is China Resources Pharmaceutical Group Ltd.’s market cap?
China Resources Pharmaceutical Group Ltd.’s market cap is HK$29.03B.
When is China Resources Pharmaceutical Group Ltd.’s upcoming earnings report date?
China Resources Pharmaceutical Group Ltd.’s upcoming earnings report date is Mar 24, 2026 which is in 7 days.
How were China Resources Pharmaceutical Group Ltd.’s earnings last quarter?
China Resources Pharmaceutical Group Ltd. released its earnings results on Aug 26, 2025. The company reported HK$0.372 earnings per share for the quarter, missing the consensus estimate of HK$0.431 by -HK$0.06.
Is China Resources Pharmaceutical Group Ltd. overvalued?
According to Wall Street analysts China Resources Pharmaceutical Group Ltd.’s price is currently Overvalued.
Does China Resources Pharmaceutical Group Ltd. pay dividends?
China Resources Pharmaceutical Group Ltd. pays a Quarterly dividend of HK$0.079 which represents an annual dividend yield of 2.95%. See more information on China Resources Pharmaceutical Group Ltd. dividends here
What is China Resources Pharmaceutical Group Ltd.’s EPS estimate?
China Resources Pharmaceutical Group Ltd.’s EPS estimate is 0.23.
How many shares outstanding does China Resources Pharmaceutical Group Ltd. have?
China Resources Pharmaceutical Group Ltd. has 6,282,510,300 shares outstanding.
What happened to China Resources Pharmaceutical Group Ltd.’s price movement after its last earnings report?
China Resources Pharmaceutical Group Ltd. reported an EPS of HK$0.372 in its last earnings report, missing expectations of HK$0.431. Following the earnings report the stock price went down -1.519%.
Which hedge fund is a major shareholder of China Resources Pharmaceutical Group Ltd.?
Currently, no hedge funds are holding shares in HK:3320
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
China Resources Pharmaceutical Group Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
5.79%
Trailing 12-Months
Asset Growth
-0.29%
Trailing 12-Months
Company Description
China Resources Pharmaceutical Group Ltd.
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and Hong Kong. The company operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. It offers a range of chemical drugs, Chinese medicines, and biopharmaceutical drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular, alimentary tract, metabolism and endocrine, respiratory, orthopedics, oncology, medical nutrition, gastroenterology, pediatrics, genitourinary system, cough and cold, anti-infection, dermatology, infusion solutions, etc. The company also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it is involved in property holding activities. As of December 31, 2021, the company operated 801 retail pharmacies under the CR Care and Teck Soon Hong brands. It distributes its products to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
Technical Analysis
China Medical System Holdings
―
Guangzhou Baiyunshan Pharmaceutical Holdings Company
―
Livzon Pharmaceutical Group
―
Shanghai Fosun Pharmaceutical (Group) Co
―
Grand Pharmaceutical Group Limited
―
Options Prices
Currently, No data available
---